15. Types of bonds
Antibodies bind reversibly to epitopes through non-covalent
interactions which include
Hydrogen bonds
Ionic bonds
Hydrophobic bonds
16. Factors Affecting Antigen-Antibody Interaction
1- Temperature:
It depends on the chemical nature of epitopes, and bonds involved.
Example
hydrogen bonds are stable at low temperatures
Hydrophobic bonds are stable at high temperatures.
17. Factors Affecting Antigen-Antibody Interaction
2- pH:
Optimal pH range is 6.5 to 8.5.
Extreme pH values change the conformation of antibodies and
inhibit the reaction.
18. Factors Affecting Antigen-Antibody Interaction
3- Concentrations of Ag and Ab:
Increase in the concentration of antigen and antibody enhances the
reaction.
Antigen + Antibody ⇄ Ag-Ab complex
25. ELISA vs immunochromatography
Area reaction in Immunochromatographic is small, so low amount of
Ag/Ab can give false negative results (lower sensitivity)
26. ELISA vs immunochromatography
No washing in Immunochromatographic, so Abs that bind weakly
can give false positive results (lower specificity)
32. Heterophile Antibodies
They can bind to Igs of other species, including the species
used to generate the antibodies used as reagents for
immunoassays
interfere with test results
34. Common heterophilic interfering antibodies
1- Rheumatoid factor
•autoantibodies (usually IgM isotype)
•Found in patients with RA
35. Common heterophile interfering antibodies
1- Rheumatoid factor
•Found in 1% to 4% of the general population
•can react against different species of Fc-IgG, including
human and rabbit.
36. Common interfering antibodies
2- Human anti-animal antibodies (HAAAs)
Human anti-mouse antibodies (HAMA)*
They are human antibodies which can bind specifically mouse
antibodies.
They could be both HAMA-IgG or HAMA-IgM subtypes.
41. Heterophile blocking reagents
They must be the same species of capture and detection
assays Abs
so typically more than
one type must be used
42. Heterophile blocking reagents
Characteristic of ideal HBR
1- It should have the ability to correct interference from all
samples
2- It should be effective at low concentrations
3- It should not interfere with linearity of dilution of a true
positive patient sample.